Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.23 USD
Change Today -0.02 / -1.60%
Volume 1.4M
PPHM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for peregrine pharmaceuticals (PPHM)

Year over year, Peregrine Pharmaceuticals, Inc. has seen their bottom line shrink from a loss of $35.4M USD to an even larger loss of $50.4M USD despite an increase in revenues from $22.4M USD to $26.8M USD.
Currency in
Millions of US Dollars
As of:Apr 30
2012
Apr 30
2013
Apr 30
2014
Apr 30
2015
4 Year
Trend
Revenues15.221.722.426.8
TOTAL REVENUES15.221.722.426.8
Cost of Goods Sold10.212.613.115.6
GROSS PROFIT5.19.19.311.2
Selling General & Admin Expenses, Total11.513.117.318.7
R&D Expenses35.724.327.743.0
OTHER OPERATING EXPENSES, TOTAL47.237.445.061.7
OPERATING INCOME-42.1-28.4-35.7-50.5
Interest Expense-0.1-0.10.00.0
Interest and Investment Income0.00.30.30.1
NET INTEREST EXPENSE0.00.30.30.1
EBT, EXCLUDING UNUSUAL ITEMS-42.1-28.1-35.4-50.4
Other Unusual Items, Total---1.7----
Other Unusual Items---1.7----
EBT, INCLUDING UNUSUAL ITEMS-42.1-29.8-35.4-50.4
Earnings from Continuing Operations-42.1-29.8-35.4-50.4
NET INCOME-42.1-29.8-35.4-50.4
NET INCOME TO COMMON INCLUDING EXTRA ITEMS-42.1-29.8-35.8-54.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS-42.1-29.8-35.8-54.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PPHM:US $1.23 USD -0.02

PPHM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aduro Biotech Inc $26.22 USD +0.43
Inovio Pharmaceuticals Inc $7.29 USD +0.08
Progenics Pharmaceuticals Inc $8.66 USD +0.20
Transgene SA €2.87 EUR +0.06
Vical Inc $0.64 USD +0.014
View Industry Companies
 

Industry Analysis

PPHM

Industry Average

Valuation PPHM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.8x
Price/Book 4.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PEREGRINE PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.